Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

AlzeCure Pharma

1.93 SEK

-1.53 %

Less than 1K followers

ALZCUR

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for AlzeCure Pharma

EV/EBIT

Median 2019-2021

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)3.537.805.123.712.791.092.00
Shares43.943.943.956.669.392.9114.9
Market cap154.8342.2224.7210.0193.1101.5229.8
Enterprise value-27.7229.7183.0----
EV/S-------
EV/EBITDA0.5neg.neg.----
EV/EBIT0.5neg.neg.----
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B0.853.096.813.478.123.886.98
P/S-------
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio97.5 %94.0 %72.2 %85.4 %74.3 %76.0 %55.8 %
Gearing ratio------7.8 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.